US watchdog eases way for GSK vaccine

US regulators have downplayed safety concerns over GlaxoSmithKline’s vaccine against cervical cancer in a decision that will have repercussions for many other vaccines, including those to protect against the pandemic flu virus.Documents made public ahead of an advisory committee of the Food & Drug Administration on Wednesday downplay previous concerns over Cervarix, paving the way for the likely approval of the first vaccine in the US in 80 years to contain a patented “adjuvant” to enhance effic...
From:http://www.ft.com/cms/s/0/dd7c9258-9b08-11de-a3a1-00144feabdc0.html